Results 71 to 80 of about 136,043 (299)

Can TERT rs2853669 polymorphysm indicate fibrosis in sarcoidosis? [PDF]

, 2023
Sümeyye Kement, Eda Turgut Uğurtay, Aslı Tanrıvermiş Sayit, Pınar Tascı, Meftun Ünsal   +4 more
openalex   +1 more source

Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells [PDF]

, 2016
Background Sarcoidosis is a multisystem immuno-inflammatory disorder of unknown etiology that most commonly involves the lungs. We hypothesized that an unbiased approach to identify pathways activated in bronchoalveolar lavage (BAL ...
A Malur, A Subramanian, AI Saeed, B Guillaume, BM Bolstad, D Merico, D Szklarczyk, D Valeyre, DA Ferrington, E Kruger, ED Crouser, EE Schadt, F Larousserie, G Kar, G Nalepa, GW Hunninghake, J Grunewald, J Wahlstrom, J Wang, JD Storey, JE Snyder-Cappione, K Fellenberg, K Osolnik, LH Hartwell, LL Koth, LS Newman, M Ashburner, M Facco, M Karin, M Vidal, MA Judson, MA Judson, MA Kayala, MC Iannuzzi, MJ Edelmann, MS Cline, P Korosec, R Su, R Su, S Ringkowski, SE Calvano, SU Sixt, TD Schmittgen, Y Ben-Neriah   +43 more
core   +3 more sources

A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection [PDF]

, 2020
Introduction: During the coronavirus disease 2019 (COVID-19) pandemic, emergency providers are not only seeing an increasing number of patients with COVID-19 infections, but also associated complications and sequelae of this viral illness.Case Report: We
Bilello, Leslie A., Sarma, Deesha
core  

Imaging infection and inflammation [PDF]

, 2015
No abstract ...
A. W., Glaudemans, F., Rouzet, Galli, Filippo, Signore, Alberto   +3 more
core   +1 more source

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Clinical Pharmacology &Therapeutics, EarlyView.
Extended interval dosing regimens of immune checkpoint inhibitors have been implemented widely. However, their approval was mainly based on pharmacokinetic modeling and simulations. Consequently, comparative safety data of extended interval dosing regimens in a real‐world setting are limited.
Ruben Malmberg, Maaike M. Hofman, Fatima Ashad, Alaa Daloul, Stefani Oosterveld, Edwin A. Basak, Esther Oomen‐de Hoop, Astrid A. M. van der Veldt, Arjen Joosse, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen   +10 more
wiley   +1 more source

Ankylosing spondylitis and sarcoidosis — Coincidence or association? [PDF]

, 1992
We report a 25-year-old woman presenting with sarcoidosis and bilateral sacroiliitis. Her sarcoidosis related symptoms (malaise, cough and dyspnoea) improved dramatically under treatment with steroids but severe back pain persisted.
Felten, A. von, Michel, B. A., Speich, R., Stucki, Gerold   +3 more
core   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Innovating care for people with sarcoidosis using a machine learning-driven approach

Respiratory Research
Introduction Understanding patients’ everyday experience is essential to improve patient centered care in sarcoidosis. So far, patient perspectives are based on survey- and qualitative research. Aim We aimed to assess patient-driven perspectives on their
Vivienne Kahlmann, Astrid Dunweg, Heleen Kicken, Nick Jelicic, Johanna M. Hendriks, Richard Goossens, Marlies S. Wijsenbeek, Jiwon Jung   +7 more
doaj   +1 more source

Ocular sarcoidosis, to screen or not to screen?

Frontiers in Medicine
Ocular sarcoidosis most commonly presents with symptoms and is first diagnosed before systemic sarcoidosis in at least half of the patients with sarcoidosis.
Sanna Leinonen, Sanna Leinonen
doaj   +1 more source

Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis

Clinical Case Reports, 2019
Key Clinical Message Steroids used to treat sarcoidosis may induce aPAP. The cooccurrence of sarcoidosis and autoimmune pulmonary alveolar proteinosis (aPAP) is rare.
Yuko Tanaka, Toshihiro Shirai, Kazuhiro Asada, Aya Muramatsu, Mineo Katsumata, Takafumi Suda   +5 more
doaj   +1 more source